Judi Ng Cashin is the Chief Medical Officer of our Company. She brings a wealth of experience to the team in both early and late stage drug development with major pharmaceutical companies where she managed clinical research, interacted with the FDA, and developed clinical and portfolio strategies. Most recently, Judi served as Chief Scientific Officer at Syneos Health, a pharmaceutical services provider created by the merger of INC Research and inVentiv Health, where she led the integration of the therapeutic, medical, and scientific operations within product development and Phase 1-4 trial delivery. Prior to Syneos, Judi served as the Vice President of Medical Strategy and then of Advisory Services for IQVIA, formerly Quintiles, a management consultancy focused on biopharma and the healthcare industry. Her experience also includes nine years with GlaxoSmithKline (GSK) in senior medical leadership roles including, Vice President of Medical Excellence and Quality, Vice President and Global Head, Infectious Diseases Medicines Development Center, as well as Vice President of Stiefel Laboratories, GSK’s dermatology franchise focusing on acne treatments and anti-infectives.